# Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

> **NCT07089381** · NA · RECRUITING · sponsor: **Ain Shams University** · enrollment: 118 (estimated)

## Conditions studied

- Rheumatic Arthritis
- Rheumatoid Arthritis (RA) Prevention
- Inflamation
- Antioxidant
- Anti Oxidative Stress
- Anti Aging
- C Reactive Protein
- Methotrexate
- Quality of Life Outcomes

## Interventions

- **DIETARY_SUPPLEMENT:** Resveratrol 1 gm.
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT07089381
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089381, "Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07089381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*